Search

In November 2014, the Heart Rhythm Society (HRS) and National Stroke Association, in collaboration with Boehringer Ingelheim (BI), shared results from a survey of more than 1,200 respondents to evaluate the impact of AFib and stroke on patients and caregivers, and the concurrent perceptions physicians have about treatment options and their patients’ understanding of issues surrounding the condition.